KR101666144B1 - 리포펩티드를 정제하는 방법 - Google Patents

리포펩티드를 정제하는 방법 Download PDF

Info

Publication number
KR101666144B1
KR101666144B1 KR1020117021714A KR20117021714A KR101666144B1 KR 101666144 B1 KR101666144 B1 KR 101666144B1 KR 1020117021714 A KR1020117021714 A KR 1020117021714A KR 20117021714 A KR20117021714 A KR 20117021714A KR 101666144 B1 KR101666144 B1 KR 101666144B1
Authority
KR
South Korea
Prior art keywords
solution
elution buffer
phase chromatography
reverse phase
chromatography column
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020117021714A
Other languages
English (en)
Korean (ko)
Other versions
KR20110134884A (ko
Inventor
마틴 맨슨
엘리 카린 데일
시셀 하우게
카르스텐 오버발레-페터젠
크저스티 아아스토르프 히르쓰
데니스 브라이언 한센
Original Assignee
셀리아 파마슈티칼즈 에이피에스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42116034&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR101666144(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 셀리아 파마슈티칼즈 에이피에스 filed Critical 셀리아 파마슈티칼즈 에이피에스
Publication of KR20110134884A publication Critical patent/KR20110134884A/ko
Application granted granted Critical
Publication of KR101666144B1 publication Critical patent/KR101666144B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020117021714A 2009-02-19 2010-02-19 리포펩티드를 정제하는 방법 Active KR101666144B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15366009P 2009-02-19 2009-02-19
US61/153,660 2009-02-19
PCT/NO2010/000066 WO2010095953A1 (en) 2009-02-19 2010-02-19 Process for purifying lipopeptides

Publications (2)

Publication Number Publication Date
KR20110134884A KR20110134884A (ko) 2011-12-15
KR101666144B1 true KR101666144B1 (ko) 2016-10-13

Family

ID=42116034

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020117021714A Active KR101666144B1 (ko) 2009-02-19 2010-02-19 리포펩티드를 정제하는 방법

Country Status (21)

Country Link
US (1) US9150894B2 (enExample)
EP (1) EP2398817B2 (enExample)
JP (1) JP5752609B2 (enExample)
KR (1) KR101666144B1 (enExample)
CN (1) CN102325785B (enExample)
AU (1) AU2010216475B2 (enExample)
BR (1) BRPI1008300B1 (enExample)
CA (1) CA2748932C (enExample)
DK (1) DK2398817T4 (enExample)
ES (1) ES2543457T5 (enExample)
HR (1) HRP20150761T4 (enExample)
HU (1) HUE026818T2 (enExample)
IL (1) IL214374A (enExample)
MX (1) MX2011008621A (enExample)
PL (1) PL2398817T5 (enExample)
PT (1) PT2398817E (enExample)
RU (1) RU2526391C2 (enExample)
SI (1) SI2398817T2 (enExample)
UA (1) UA105785C2 (enExample)
WO (1) WO2010095953A1 (enExample)
ZA (1) ZA201104848B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2526391C2 (ru) 2009-02-19 2014-08-20 Кселлия Фармасьютикалз Апс Способ очистки липопептидов
CN102690329B (zh) * 2011-03-25 2014-06-04 杭州九源基因工程有限公司 一种戈舍瑞林多肽的纯化生产方法
CN102875652A (zh) * 2011-07-13 2013-01-16 北大方正集团有限公司 一种分离纯化达托霉素的方法
CN103159829B (zh) * 2011-12-08 2014-11-05 北大方正集团有限公司 达托霉素的提取方法
CN102675426B (zh) * 2012-04-26 2013-12-11 杭州华东医药集团生物工程研究所有限公司 一种达托霉素的提取纯化方法
CN102924572B (zh) * 2012-11-12 2014-12-03 华北制药集团新药研究开发有限责任公司 一种高纯度达托霉素的制备方法
CN104387444B (zh) * 2014-11-13 2017-12-08 北大医药重庆大新药业股份有限公司 一种达托霉素杂质rs‑2高纯度样品的制备方法
EP3233230B1 (en) * 2014-12-15 2024-06-12 Merck Patent GmbH Target molecule capture from crude solutions
CN105001305A (zh) * 2015-04-29 2015-10-28 利穗科技(苏州)有限公司 利用层析技术提取高纯度达托霉素的方法
CN105481950B (zh) * 2016-01-28 2019-01-04 丽珠集团福州福兴医药有限公司 一种达托霉素提取方法
IT201600127655A1 (it) 2016-12-16 2018-06-16 Gnosis Spa Processo per la purificazione di antibiotici lipopolipeptidici
CN108250270A (zh) * 2016-12-29 2018-07-06 天津领世生物科技开发有限公司 一种从发酵液中富集提取达托霉素的方法
CN112979756B (zh) * 2019-12-13 2023-01-03 浙江昌海制药有限公司 达托霉素的提纯方法
CN113004373B (zh) * 2019-12-19 2024-08-13 鲁南制药集团股份有限公司 一种达托霉素的纯化方法
RU2762182C1 (ru) * 2020-12-08 2021-12-16 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт по изысканию новых антибиотиков имени Г.Ф. Гаузе" Гауземицины А и В - гликолипопептидные антибактериальные антибиотики и способ их получения
CN113340691B (zh) * 2021-06-05 2023-12-12 清华大学 一种提取海洋沉积物中不同赋存形态磷的方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070191280A1 (en) * 2000-01-20 2007-08-16 Thomas Kelleher High Purity Lipopeptides

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537717A (en) 1982-05-21 1985-08-27 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4885243A (en) 1984-10-09 1989-12-05 Eli Lilly And Company Process for producing A-21978C derivatives
US4667016A (en) 1985-06-20 1987-05-19 Kirin-Amgen, Inc. Erythropoietin purification
ZA883887B (en) 1987-06-10 1990-02-28 Lilly Co Eli Chromatographic purification process
US4874843A (en) 1987-12-03 1989-10-17 Eli Lilly And Company Chromatographic purification process
JP2661790B2 (ja) * 1990-11-27 1997-10-08 電気化学工業株式会社 入尿トリプシンインヒビターの精製方法
ZA946122B (en) * 1993-08-17 1995-03-20 Amgen Inc Erythropoietin analogs
US5650496A (en) 1995-04-14 1997-07-22 Cephalon, Inc. IGF-I purification process
AU2002246688A1 (en) * 2000-12-18 2002-07-30 Altus Biologics Inc. Methods for preparing purified daptomycin
US20060014674A1 (en) 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
JP2010505874A (ja) * 2006-10-03 2010-02-25 ノヴォ ノルディスク アー／エス ポリペプチドコンジュゲートの精製方法
WO2009144739A1 (en) * 2008-05-26 2009-12-03 Biocon Limited Amorphous daptomycin and a method of purification thereof
RU2526391C2 (ru) 2009-02-19 2014-08-20 Кселлия Фармасьютикалз Апс Способ очистки липопептидов
CN101899094B (zh) * 2009-06-01 2012-11-21 安徽丰原发酵技术工程研究有限公司 一种高纯达托霉素的制备方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070191280A1 (en) * 2000-01-20 2007-08-16 Thomas Kelleher High Purity Lipopeptides

Also Published As

Publication number Publication date
DK2398817T4 (da) 2021-08-23
US9150894B2 (en) 2015-10-06
CA2748932A1 (en) 2010-08-26
IL214374A0 (en) 2011-09-27
AU2010216475A1 (en) 2011-08-11
ZA201104848B (en) 2012-10-31
CN102325785B (zh) 2015-01-21
EP2398817A1 (en) 2011-12-28
PT2398817E (pt) 2015-08-28
US20100228006A1 (en) 2010-09-09
EP2398817B1 (en) 2015-04-29
ES2543457T5 (es) 2021-12-22
HRP20150761T1 (hr) 2015-08-14
CA2748932C (en) 2019-11-19
BRPI1008300A8 (pt) 2021-05-11
KR20110134884A (ko) 2011-12-15
HRP20150761T4 (hr) 2021-08-06
WO2010095953A1 (en) 2010-08-26
IL214374A (en) 2017-03-30
PL2398817T3 (pl) 2015-10-30
SI2398817T2 (sl) 2021-09-30
DK2398817T3 (en) 2015-07-27
RU2526391C2 (ru) 2014-08-20
JP5752609B2 (ja) 2015-07-22
EP2398817B2 (en) 2021-06-23
MX2011008621A (es) 2011-09-15
BRPI1008300A2 (pt) 2016-03-15
HUE026818T2 (en) 2016-07-28
BRPI1008300B1 (pt) 2021-07-13
ES2543457T3 (es) 2015-08-19
AU2010216475B2 (en) 2015-07-09
RU2011137010A (ru) 2013-03-27
CN102325785A (zh) 2012-01-18
PL2398817T5 (pl) 2021-10-04
UA105785C2 (uk) 2014-06-25
JP2012518034A (ja) 2012-08-09
SI2398817T1 (sl) 2015-08-31

Similar Documents

Publication Publication Date Title
KR101666144B1 (ko) 리포펩티드를 정제하는 방법
EP2236513B1 (en) An improved purification process for lipopeptides
JP7566762B2 (ja) 陰イオン交換クロマトグラフィーを使用した生物学的分子、例えばプラスミドｄｎａなどのための精製プロセス
DE69019464T2 (de) Verfahren zur Rückgewinnung von Antibiotikum A/16686.
CN104066747A (zh) 替考拉宁的纯化方法
US7192743B2 (en) Method of producing teicoplanin
CN112979756A (zh) 达托霉素的提纯方法
JPH10295396A (ja) モエノマイシンａの製造法
Quinn¹ Chemistry of aqueous marine extracts: Isolation techniques
US20210355160A1 (en) Process for the purification of lipopolypeptide antibiotics
CA2752784A1 (en) Daptomycin formulation
KR102040344B1 (ko) 테이코플라닌의 정제 방법
US20230312540A1 (en) Method for extracting mupirocin
JPH0121836B2 (enExample)

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10